Therapeutic use of intravenous immunoglobulins in the antiphospholipid syndrome;Utilisation therapeutique des immunoglobulines intraveineuses au cours du syndrome des anti-phospholipides

Annales de Medecine Interne

Volumn 151, Issue SUPPL. 1, 2000, Pages

  Piette, Jean Charles ^a   Le Thi Huong Du ^a   Wechsler, Bertrand ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiphospholipid syndrome; In vitro fertilization failure; Intravenous immunoglobulin therapy

Indexed keywords

ACETYLSALICYLIC ACID; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; HEPARIN; IMMUNOGLOBULIN; PHOSPHOLIPID ANTIBODY; STEROID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ANTIPHOSPHOLIPID SYNDROME; DRUG EFFICACY; DRUG MECHANISM; FERTILIZATION IN VITRO; HUMAN; REVIEW; THROMBOCYTOPENIA; FEMALE; PREGNANCY; RECURRENT ABORTION; SPONTANEOUS ABORTION;

ABORTION, HABITUAL; ABORTION, SPONTANEOUS; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; FEMALE; FERTILIZATION IN VITRO; HEPARIN; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PLATELET AGGREGATION INHIBITORS; PREGNANCY; THROMBOCYTOPENIA;

EID: 0343962582     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. WILSON WA, GHARAVI AE, KOIKE T, LOCKSHIN MD, BRANCH DW, PIETTE JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 1999; 42: 1309-11.
2. KHAMASHTA MA, CUADRADO MJ, MUJIC F, TAUB NA, HUNT BJ, HUGHES GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med, 1995; 332: 993-7.
3. KUTTEH WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol, 1996; 174: 1584-9.
4. RAI R, COHEN H, DAVE M, REGAN L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ, 1997; 314: 253-7.
5. ASHERSON RA, CERVERA R, PIETTE JC, FONT J, LIE JT, BURCOGLU A, et al. "Catastrophic" antiphospholipid syndrome: clinical and laboratory features of 50 patients. Medicine (Baltimore), 1998; 77: 195-207.
6. PAPO T, PIETTE JC. Syndrome catastrophique des antiphospholipides. Sang Thrombose Vaisseaux, 1999; 11: 150-4.
7. HARRIS EN, PIERANGELI SS: Utilization of intravenous immunoglobulins therapy to treat recurrent pregnancy loss in the antiphospholipid syndrome: a review. Scand J Rheumatol, 1998; 27 (Suppl. 27): 97-102.
8. SOMERSET DA, RAINE-FENNING N, GORDON C, WEAVER JB, KILBY MD. Intravenous immunoglobulin therapy in compromised pregnancies associated with antiphospholipid antibodies and systemic lupus erythematosus. Eur J Obstet Gynecol Reprod Biol, 1998; 79: 227-9.
9. BLETRY O, BLANC AS, PIETTE AM. Intérêt des immunoglobulines intraveineuses au cours du syndrome des antiphospholipides. Rev Med Interne, 1999; 20 (Suppl 4): 410-3.
10. VALENSISE H, VAQUERO E, DE CAROLIS C, STIPA E, PERRICONE R, ARDUINI D, et al. Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG). Prenat Diagn, 1995; 15:509-17.
11. MARZUSCH K, DIETL J, KLEIN R, HORNUNG D, NEUER A, BERG PA: Recurrent first trimester spontaneous abortion associated with antiphospholipid antibodies: a pilot study of treatment with intravenous immunoglobulin. Acta Obstet Gynecol Scand, 1996; 75: 922-6.
12. CLARK AL, BRANCH DW, SILVER RM, HARRIS EN, PIERANGELI S, SPINNATO JA. Pregnancy complicated by the antiphospholipid syndrome: outcomes with intravenous immunoglobulin therapy. Obstet Gynecol, 1999; 93: 437-41.
13. SPINNATO JA, CLARK AL. PIERANGELI SS, HARRIS EN. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy. Am J Obstet Gynecol, 1995; 172: 690-4.
14. BLETRY O, LARAKI R, COSSERAT J, WECHSLER B, PIETTE JC. Rôle des antiphospholipides au cours des pertes fœtales. Presse Med ,1992 ; 21 : 1813-9.
15. PIETTE JC. Towards improved criteria for the antiphospholipid syndrome. Lupus, 1998; 7 (Suppl 2): S149-57.
16. GORDON C, KILBY MD. Use of intravenous immunoglobulin therapy in pregnancy in systemic lupus erythematosus and antiphospholipid antibody syndrome. Lupus, 1998; 7: 429-33.
17. BAKIMER R, GUILBURD B, ZURGIL N, SHOENFELD Y. The effect of intravenous gamma-globulin on the induction of experimental antiphospholipid syndrome. Clin Immunol Immunopathol, 1993; 69: 97-102.
18. BRANCH DW, HATASAKA HH. Antiphospholipid antibodies and infertility: fact or fallacy. Lupus, 1998; 7 (suppl 2): S90-4.
19. KUTTEH WH, YETMAN DL, CHANTILIS SJ, CRAIN J. Effect of antiphospholipid antibodies in women undergoing in-vitro fertilization: Role of heparin and aspirin. Hum Reprod, 1997; 6: 1171-5.
20. STHOEGER ZM, MOZES E, TARTAKOVSKY B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proc Natl Acad Sci USA, 1993; 90: 6464-7.
21. SHER G, ZOUVES C, FEINMAN M, MAASSARANI G, MATZNER W, CHONG P, et al. A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid antibodies. Am J Reprod Immunol, 1998; 39: 391-4.
22. SHER G, MATZNER W, FEINMAN M, MAASSARANI G, ZOUVES C, CHONG P, et al. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol, 1998; 40: 74-82.
23. LE THI HUONG DU, WECHSLER B, PIETTE JC, ARFI S, GALLINARI C, DARBOIS Y, et al. Risks of ovulation-induction therapy in systemic lupus erythematosus. Br J Rheumatol, 1996; 35: 1184-6.
24. WECHSLER B, LE THI HUONG DU, VAUTHIER-BROUZES D, LEFEBVRE G, GOMPEL A, PIETTE JC. Can we advise ovulation induction in patients with SLE? Scand J Rheumatol, 1998; 27 Suppl 107: 53-9.
25. SHER G, MAASSARANI G, ZOUVES C, FEINMAN M, SOHN S, MATZNER W, et al. The use of combined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodies. Am J Reprod Immunol, 1998; 39: 223-5.
26. DAVIES KA, ATHANASSIOU P, LOIZOU SA. Thrombocytopenia and other haematological abnormalities in the antiphospholipid syndrome. In: ASHERSON RA, CERVERA R, PIETTE JC, SHOENFELD Y, eds. The antiphospholipid syndrome. Boca Raton : CRC Press, 1996 : 219-34.
27. GODEAU B, PIETTE JC, FROMONT P, INTRATOR L, SCHAEFFER A, BIERLING P. Specific antiplatelet glycoprotein auto-antibodies are associated with the thrombocytopenia of primary antiphospholipid syndrome. Br J Haematol, 1997; 98: 873-9.
28. ARNAL C, BIERLING P, PAPO T, TAILLAN B, LEONE J, HACHULLA E, et al. Treatment of severe thrombocytopenia within systemic lupus erythematosus: study of 67 cases (abstract). Arthritis Rheum, 1998; 41 (Suppl): S110.
29. COSTEDOAT-CHALUMEAU N, AMOURA Z, AYMARD G, SEVIN O, WECHSLER B, CACOUB P, et al. Potentiation of vitamin K-antagonists by high-dose intravenous methylprednisolone. Ann Intern Med (in press).
30. VANDENBERGHE P, ZACHEE P, VERSTRAETE S, DEMUYNCK H, BOOGAERTS MA, VERHOEF GE. Successful control of refractory and life-threatening autoimmune hemolytic anemia with intravenous immunoglobulins in a man with the primary antiphospholipid syndrome. Ann Hematol, 1996; 73: 253-6.
31. HANLEY D, ARKEL YS, LYNCH J, KAMIYAMA M. Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am J Hematol, 1994; 46: 141-6.
32. VIVALDI P, ROSSETTI G, GALLI M, FINAZZI G. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Haematologica, 1997; 82: 345-7.
33. YU Z, LENNON VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med, 1999; 340: 227-8.
34. ARNOUT J, SPITZ B, WITTEVRONGEL C, VANRUSSELT M, VAN ASSCHE A, VERMYLEN J. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome: immunological changes associated with a successful outcome. Thromb Haemost, 1994; 71: 741-7.
35. KAAJA R, JULKUNEN H, AMMALA P, PALOSUO T, KURKI P. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy losses associated with antiphospholipid antibodies. Acta Obstet Gynecol Scand, 1993; 72: 63-6.
36. COSSERAT J, BLETRY O, HORELLOU MH, WEILL B, LARAKI R, PIETTE JC, et al. Treatment of antiphospholipid antibody syndrome with intravenous immunoglobulins (abstract). Lupus, 1992; 1 (Suppl 1): 46.
37. PIETTE JC, WECHSLER B. Maladies orphelines et société. III - Utilisation thérapeutique des immunoglobulines en Médecine Interne. Rev Med Interne, 1999 ; 20 (suppl 4) : 407-9.